IRIS
PRONZATO, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.065
Totale 2.065
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 2.065
Totale 2.065
Salva come PNG Salva come JPEG
Città #
Genova 1.145
Rapallo 328
Vado Ligure 308
Genoa 277
Bordighera 7
Totale 2.065
Salva come PNG Salva come JPEG
Nome #
5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial 128
Role of fulvestrant in the treatment of postmenopausal metastatic breast cancer patients 117
Hormonal therapy followed by chemotherapy or the reverse sequence as first-line treatment of hormone-responsive, human epidermal growth factor receptor-2 negative metastatic breast cancer patients: Results of an observational study 117
New insights on the role of luteinizing hormone releasing hormone agonists in premenopausal early breast cancer patients 116
Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and taxane-based chemotherapy in breast cancer patients: a single-center experience within the GIM2 randomized phase III trial 115
Luteinising hormone releasing hormone agonists (LH-RHa) in premenopausal early breast cancer patients: current role and future perspectives 102
Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis 100
Estrone sulphate, FSH, and testosterone levels in two male breast cancer patients treated with aromatase inhibitors 96
Timing of adjuvant chemotherapy and tamoxifen in women with breast cancer: findings from two consecutive trials of Gruppo Oncologico Nord-Ovest-Mammella Intergruppo (GONO-MIG) Group 91
Pegfilgrastim for the prevention of chemotherapy-induced febrile neutropenia in patients with solid tumors 90
Medical approaches to preservation of fertility in female cancer patients 89
Stevens-johnson syndrome after treatment with bendamustine 83
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: Final results of the phase III randomized Short-HER study 83
Trastuzumab emtansine in the treatment of HER-2-positive metastatic breast cancer patients 77
Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival A Randomized Clinical Trial 72
Use in current clinical practice of 70-gene signature in early breast cancer 71
Trastuzumab as first-line therapy in HER2-positive metastatic breast cancer patients. 69
Economic Impact of Inter-Regional Health Mobility In The Oldest European Administrative Region: A Starting Point For Changing Organizational Model? 68
Endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: Extending endocrine sensitivity 62
Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial. 60
A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients 52
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies 46
Immunotherapy-chemotherapy combinations for non-small cell lung cancer: current trends and future perspectives 39
Diagnosis of lung cancer following emergency admission: Examining care pathways, clinical outcomes, and advanced NSCLC treatment in an Italian cancer Center 36
Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literature 33
Experience with a nurse-driven genetic counseling pathway of Italian women with uninformative BRCA test result 27
Activity and safety of first-line treatments for advanced melanoma: A network meta-analysis 20
Patterns of care at the end of life: a retrospective study of Italian patients with advanced breast cancer 19
Corrigendum to "Gene expression profiling in breast cancer: A clinical perspective" [The Breast 22 (2013) 109-120 [doi:10.1016/j.breast.2013.01.016.]] 14
The Impact of the Introduction of the Breast Unit Model in a Northwestern Italian Region 14
Clinical Outcomes of HER2-Negative Metastatic Breast Cancer Patients in Italy in the Last Decade: Results of the GIM 13-AMBRA Study 13
Thymidine labeling index analysis in early breast cancer patients randomized to receive perioperative chemotherapy 12
Intramuscular depot medroxyprogesterone versus oral megestrol for the control of postmenopausal hot flashes in breast cancer patients: A randomised study 10
Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study 9
Practices and views about palliative care at the end of life: A survey of oncologists from the Italian region of Liguria 7
Totale 2.157
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.393
article - articoli 9.393
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.786
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020447 0 0 0 0 0 79 101 59 56 86 52 14
2020/2021182 9 20 8 36 9 8 12 22 9 25 9 15
2021/2022229 12 10 9 27 3 31 4 48 22 29 7 27
2022/2023372 25 37 5 24 73 58 4 40 60 10 35 1
2023/2024235 9 27 6 36 19 18 34 9 9 17 8 43
2024/2025335 35 54 23 52 92 79 0 0 0 0 0 0
Totale 2.157